- call +1-201-465-4211
- email sales@mrinsights.biz
Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cells in whole blood in suspension; this makes plasma the extracellular matrix of blood cells.
Scope of the Report:
Platelets have no cell nucleus: they are fragments of cytoplasm that are derived from the megakaryocytes of the bone marrow, and then enter the circulation. Circulating unactivated platelets are biconvex discoid (lens-shaped) structures,2–3 µm in greatest diameter. Platelets are found only in mammals, whereas in other animals (e.g. birds, amphibians) thrombocytes circulate as intact mononuclear cells. Plasma makes up about 55% of the body's total blood volume.It is the intravascular fluid part of extracellular fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and contains dissolved proteins (6–8%) (i.e.—serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3−, Cl−, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation) and oxygen. Plasma also serves as the protein reserve of the human body. It plays a vital role in an intravascular osmotic effect that keeps electrolytes in balanced form and protects the body from infection and other blood disorders. Rising prevalence of chronic diseases such as haemophilia, thrombocytopenia, haemorrhage, liver diseases as well as other rare and infectious diseases will drive the global platelet and plasma market.
The global Platelet and Plasma market is valued at 5800 million USD in 2017 and is expected to reach 5800 million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Platelet and Plasma.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Platelet and Plasma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Platelet and Plasma market by product type and applications/end industries.
Market Segment by Companies, this report covers
America’s Blood Centers
American Red Cross
American Association of Blood Banks
Blood Centers of America
Brazilian Red Cross
Canadian Red Cross
European Blood Alliance
French Red Cross
German Red Cross
Indian Red Cross
Italian Red Cross
Red Cross Society of China
Saudi Red Crescent Authority
South African Red Cross Society
Others
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Platelet
Plasma
Market Segment by Applications, can be divided into
Hemophilia
Thrombocytopenia
Perioperative Indications
Platelet Function Disorders
Other Platelet Applications
Coagulation Factor Deficiencies
Thrombotic Thrombocytopenic Purpura
Hemorrhage
Liver Disease
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Platelet and Plasma Market Overview
1.1 Product Overview and Scope of Platelet and Plasma
1.2 Classification of Platelet and Plasma by Types
1.2.1 Global Platelet and Plasma Revenue Comparison by Types (2017-2023)
1.2.2 Global Platelet and Plasma Revenue Market Share by Types in 2017
1.2.3 Platelet
1.2.4 Plasma
1.3 Global Platelet and Plasma Market by Application
1.3.1 Global Platelet and Plasma Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hemophilia
1.3.3 Thrombocytopenia
1.3.4 Perioperative Indications
1.3.5 Platelet Function Disorders
1.3.6 Other Platelet Applications
1.3.7 Coagulation Factor Deficiencies
1.3.8 Thrombotic Thrombocytopenic Purpura
1.3.9 Hemorrhage
1.3.10 Liver Disease
1.4 Global Platelet and Plasma Market by Regions
1.4.1 Global Platelet and Plasma Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Platelet and Plasma Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Platelet and Plasma Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Platelet and Plasma Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Platelet and Plasma Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Platelet and Plasma Status and Prospect (2013-2023)
1.5 Global Market Size of Platelet and Plasma (2013-2023)
2 Manufacturers Profiles
2.1 America’s Blood Centers
2.1.1 Business Overview
2.1.2 Platelet and Plasma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 America’s Blood Centers Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.2 American Red Cross
2.2.1 Business Overview
2.2.2 Platelet and Plasma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 American Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.3 American Association of Blood Banks
2.3.1 Business Overview
2.3.2 Platelet and Plasma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 American Association of Blood Banks Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.4 Blood Centers of America
2.4.1 Business Overview
2.4.2 Platelet and Plasma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Blood Centers of America Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.5 Brazilian Red Cross
2.5.1 Business Overview
2.5.2 Platelet and Plasma Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Brazilian Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.6 Canadian Red Cross
2.6.1 Business Overview
2.6.2 Platelet and Plasma Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Canadian Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.7 European Blood Alliance
2.7.1 Business Overview
2.7.2 Platelet and Plasma Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 European Blood Alliance Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.8 French Red Cross
2.8.1 Business Overview
2.8.2 Platelet and Plasma Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 French Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.9 German Red Cross
2.9.1 Business Overview
2.9.2 Platelet and Plasma Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 German Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.10 Indian Red Cross
2.10.1 Business Overview
2.10.2 Platelet and Plasma Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Indian Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.11 Italian Red Cross
2.11.1 Business Overview
2.11.2 Platelet and Plasma Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Italian Red Cross Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.12 Red Cross Society of China
2.12.1 Business Overview
2.12.2 Platelet and Plasma Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Red Cross Society of China Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.13 Saudi Red Crescent Authority
2.13.1 Business Overview
2.13.2 Platelet and Plasma Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Saudi Red Crescent Authority Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.14 South African Red Cross Society
2.14.1 Business Overview
2.14.2 Platelet and Plasma Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 South African Red Cross Society Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.15 Others
2.15.1 Business Overview
2.15.2 Platelet and Plasma Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Others Platelet and Plasma Revenue, Gross Margin and Market Share (2016-2017)
3 Global Platelet and Plasma Market Competition, by Players
3.1 Global Platelet and Plasma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Platelet and Plasma Players Market Share
3.2.2 Top 10 Platelet and Plasma Players Market Share
3.3 Market Competition Trend
4 Global Platelet and Plasma Market Size by Regions
4.1 Global Platelet and Plasma Revenue and Market Share by Regions
4.2 North America Platelet and Plasma Revenue and Growth Rate (2013-2018)
4.3 Europe Platelet and Plasma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Platelet and Plasma Revenue and Growth Rate (2013-2018)
4.5 South America Platelet and Plasma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Platelet and Plasma Revenue and Growth Rate (2013-2018)
5 North America Platelet and Plasma Revenue by Countries
5.1 North America Platelet and Plasma Revenue by Countries (2013-2018)
5.2 USA Platelet and Plasma Revenue and Growth Rate (2013-2018)
5.3 Canada Platelet and Plasma Revenue and Growth Rate (2013-2018)
5.4 Mexico Platelet and Plasma Revenue and Growth Rate (2013-2018)
6 Europe Platelet and Plasma Revenue by Countries
6.1 Europe Platelet and Plasma Revenue by Countries (2013-2018)
6.2 Germany Platelet and Plasma Revenue and Growth Rate (2013-2018)
6.3 UK Platelet and Plasma Revenue and Growth Rate (2013-2018)
6.4 France Platelet and Plasma Revenue and Growth Rate (2013-2018)
6.5 Russia Platelet and Plasma Revenue and Growth Rate (2013-2018)
6.6 Italy Platelet and Plasma Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Platelet and Plasma Revenue by Countries
7.1 Asia-Pacific Platelet and Plasma Revenue by Countries (2013-2018)
7.2 China Platelet and Plasma Revenue and Growth Rate (2013-2018)
7.3 Japan Platelet and Plasma Revenue and Growth Rate (2013-2018)
7.4 Korea Platelet and Plasma Revenue and Growth Rate (2013-2018)
7.5 India Platelet and Plasma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Platelet and Plasma Revenue and Growth Rate (2013-2018)
8 South America Platelet and Plasma Revenue by Countries
8.1 South America Platelet and Plasma Revenue by Countries (2013-2018)
8.2 Brazil Platelet and Plasma Revenue and Growth Rate (2013-2018)
8.3 Argentina Platelet and Plasma Revenue and Growth Rate (2013-2018)
8.4 Colombia Platelet and Plasma Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Platelet and Plasma by Countries
9.1 Middle East and Africa Platelet and Plasma Revenue by Countries (2013-2018)
9.2 Saudi Arabia Platelet and Plasma Revenue and Growth Rate (2013-2018)
9.3 UAE Platelet and Plasma Revenue and Growth Rate (2013-2018)
9.4 Egypt Platelet and Plasma Revenue and Growth Rate (2013-2018)
9.5 Nigeria Platelet and Plasma Revenue and Growth Rate (2013-2018)
9.6 South Africa Platelet and Plasma Revenue and Growth Rate (2013-2018)
10 Global Platelet and Plasma Market Segment by Type
10.1 Global Platelet and Plasma Revenue and Market Share by Type (2013-2018)
10.2 Global Platelet and Plasma Market Forecast by Type (2018-2023)
10.3 Platelet Revenue Growth Rate (2013-2023)
10.4 Plasma Revenue Growth Rate (2013-2023)
11 Global Platelet and Plasma Market Segment by Application
11.1 Global Platelet and Plasma Revenue Market Share by Application (2013-2018)
11.2 Platelet and Plasma Market Forecast by Application (2018-2023)
11.3 Hemophilia Revenue Growth (2013-2018)
11.4 Thrombocytopenia Revenue Growth (2013-2018)
11.5 Perioperative Indications Revenue Growth (2013-2018)
11.6 Platelet Function Disorders Revenue Growth (2013-2018)
11.7 Other Platelet Applications Revenue Growth (2013-2018)
11.8 Coagulation Factor Deficiencies Revenue Growth (2013-2018)
11.9 Thrombotic Thrombocytopenic Purpura Revenue Growth (2013-2018)
11.10 Hemorrhage Revenue Growth (2013-2018)
11.11 Liver Disease Revenue Growth (2013-2018)
12 Global Platelet and Plasma Market Size Forecast (2018-2023)
12.1 Global Platelet and Plasma Market Size Forecast (2018-2023)
12.2 Global Platelet and Plasma Market Forecast by Regions (2018-2023)
12.3 North America Platelet and Plasma Revenue Market Forecast (2018-2023)
12.4 Europe Platelet and Plasma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Platelet and Plasma Revenue Market Forecast (2018-2023)
12.6 South America Platelet and Plasma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Platelet and Plasma Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Platelet and Plasma Picture
Table Product Specifications of Platelet and Plasma
Table Global Platelet and Plasma and Revenue (Million USD) Market Split by Product Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
